Comelli Agnese, Focà Emanuele, Sansone Emanuele, Tomasi Cesare, Albini Elisa, Quiros-Roldan Eugenia, Tomasoni Lina Rachele, Sala Emma, Bonfanti Carlo, Caccuri Francesca, Caruso Arnaldo, De Palma Giuseppe, Castelli Francesco
University Department of Infectious and Tropical Diseases, University of Brescia and ASST Spedali Civili, 25123 Brescia, Italy.
Postgraduate School of Occupational Health, DSMC, University of Brescia, 25123 Brescia, Italy.
Microorganisms. 2021 Feb 25;9(3):488. doi: 10.3390/microorganisms9030488.
COVID-19 pandemic is requesting unprecedented efforts by health-care workers (HCWs) in all countries, and especially in Italy during the first semester of 2020.
This is a retrospective, observational study conducted at the Spedali Civili General Hospital, in Brescia, Northern Italy during the SARS CoV-2 pandemic in the first semester of 2020. Serum samples from HCWs were tested for SARS-CoV-2 spike protein-specific antibodies. An online survey was used to collect demographic, clinical, and epidemiological data.
Of the 1893 HCWs included, 433 (22.9%) were found seropositive for SARS-CoV-2 IgG. The cumulative prevalence of SARS-CoV-2 infection (antibodies production or past positive RT-PCR on nasal/throat swab) was 25.1% (475/1893). Fifty-six out of 433 (13%) seropositive participants declared to have been asymptomatic during the study period. The development of COVID-19 signs or symptoms is the main determinant of seropositivity (OR: 11.3, < 0.0001) along with their duration and severity. 40/290 (14.5%) HCWs with documented positive RT-PCR during the study period did not show any detectable antibody response. IgG levels positively correlate with age, COVID-19-compatible signs and symptoms experienced and their duration.
In this study, carried out in one of the most affected areas in Europe, we demonstrate that most HCWs with COVID-19 related symptoms develop a spike protein-specific antibodies with potential neutralizing effect.
2019冠状病毒病(COVID-19)大流行要求各国医护人员付出前所未有的努力,在2020年上半年的意大利尤其如此。
这是一项回顾性观察研究,于2020年上半年在意大利北部布雷西亚的斯佩达利奇维利综合医院进行,当时正处于严重急性呼吸综合征冠状病毒2(SARS-CoV-2)大流行期间。对医护人员的血清样本进行SARS-CoV-2刺突蛋白特异性抗体检测。通过在线调查收集人口统计学、临床和流行病学数据。
在纳入的1893名医护人员中,433人(22.9%)的SARS-CoV-2 IgG血清学检测呈阳性。SARS-CoV-2感染的累积患病率(抗体产生或既往鼻/咽拭子实时荧光定量聚合酶链反应(RT-PCR)检测呈阳性)为25.1%(475/1893)。433名血清学检测呈阳性的参与者中有56人(13%)宣称在研究期间无症状。COVID-19体征或症状的出现是血清学阳性的主要决定因素(比值比:11.3,<0.0001),同时还与其持续时间和严重程度有关。在研究期间有记录的RT-PCR检测呈阳性的290名医护人员中有40人(14.5%)未显示任何可检测到的抗体反应。IgG水平与年龄、经历的与COVID-19相符的体征和症状及其持续时间呈正相关。
在欧洲受影响最严重的地区之一进行的这项研究中,我们证明,大多数出现与COVID-19相关症状的医护人员会产生具有潜在中和作用的刺突蛋白特异性抗体。